510(k) device
Modification to Accu-Chek Active System
Roche Diagnostics Corp. · System, Test, Blood Glucose, Over The Counter (NBW, Class II) · First FDA decision Aug 9, 2001, newest Jul 3, 2002Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
5
Naming "Modification to Accu-Chek"
MAUDE reports
0
Brand "Modification to Accu-Chek", since 2015
PubMed studies
0
Mentioning "Modification to Accu-Chek"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Modification to Accu-Chek Active System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K021827 · Decided Jul 3, 2002 · 29 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Glucose TestingNational determinationOn the books190.20Updated Oct 1, 2026
- Lipid and Blood Glucose Testing (Modification of Code List to Implement Screening Benefit Added by Medicare Modernization Act (MMA)Coding analysisReview closedCAG-00266NUpdated Sep 14, 2026
- Home Blood Glucose MonitorsNational analysisReview closedCAG-00161NUpdated Sep 14, 2026
- Blood Glucose Testing (Revision of ICD-9-CM Codes for Osteomyelitis)Coding analysisReview closedCAG-00183NUpdated Sep 14, 2026
- Home Blood Glucose MonitorsNational determinationOn the books40.2Updated Dec 2, 2024
- Closed-Loop Blood Glucose Control Device (CBGCD)National determinationOn the books40.3Updated Apr 17, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Modification to Accu-Chek", any status and sponsor, newest update first.
- Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes MellitusPivotal-lookingActive, not recruiting
Hoffmann-La RocheNot on our public-company list
NCT06704672 · 270 participants (planned) · Start Apr 14, 2025 · Primary completion Jan 15, 2027
Device: Accu-Chek SmartGuide CGM Solution; Accu-Chek SmartGuide Sensor and Blinded Apps and 1 more · For: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
Sites: Gdansk, Poland; Krakow, Poland; Kraśnik, Poland · 19 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Modification to Accu-Chek", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NBW
258,305 reports: 243,487 malfunction, 14,268 injury, 39 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1591-2009 · Started May 13, 2009 · Posted by FDA Aug 11, 2009
Reason given: The lancet cap may be missing, which could result in an unintended lancet stick to the user.
Cause as FDA categorized it: Other · Device type: Glucose Dehydrogenase, Glucose (LFR)
3 more recall records with a free account
Published research
The most relevant PubMed records for "Modification to Accu-Chek"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NBW.
- RIGHTEST Blood Glucose Monitoring System Max TelBionime Corporation · 510(k) 2024
- On Call Express II Blood Glucose Monitoring SystemACON Laboratories, Inc. · 510(k) 2019
- FreeStyle Precision Neo Blood Glucose Test StripsAbbott Diabetes Care, Inc. · 510(k) 2017
- Accu-Chek Guide Solo diabetes manager blood glucose monitoring systemRoche Diabetes Care GmbH · 510(k) 2023
- POGO Automatic Blood Glucose Monitoring SystemIntuity Medical, Inc. · 510(k) 2018
- iHealth Align Gluco-Monitoring System (BG1)Andon Health Co, Ltd. · 510(k) 2017
- True Metrix Self-Monitoring Blood Glucose SystemNipro Diagnostics, Inc. · 510(k) 2014
- Clever Chek Blood Glucose Monitoring SystemTaidoc Technology Corporation · 510(k) 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.